InMed Pharmaceuticals
15 hedge funds and large institutions have $249K invested in InMed Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$22.2K | |
| 2 | +$917 | |
| 3 | +$73 | |
| 4 |
AF
Advisornet Financial
Minnetonka,
Minnesota
|
+$29 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$15 |
Top Sellers
| 1 | -$54.7K | |
| 2 | -$7.49K | |
| 3 | -$3.75K | |
| 4 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$43 |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$25 |